Roman V. Lenchine

Roman V. Lenchine

Auto-generated profile, based on publicly available information

Roman V. Lenchine

Flinders University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Current Biology
Verified
Journal Article
Closed access
JXJianling Xie
Jianling Xie
VAViviane de Souza Alves
Viviane de Souza Alves
THTobias von der Haar
Tobias von der Haar
LOLouise O’kEefe
Louise O’kEefe
RLRoman V. Lenchine
Roman V. Lenchine
CPChristopher Proud
Christopher Proud

27 December 2017 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
JXJianling Xie
Jianling Xie
KSKaikai Shen
Kaikai Shen
RLRoman V. Lenchine
Roman V. Lenchine
LGLee A. Gethings
Lee A. Gethings
PTPaul J. Trim
Paul J. Trim
CPChristopher Proud
Christopher Proud

13 March 2020 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
JXJianling Xie
Jianling Xie
KSKaikai Shen
Kaikai Shen
AJAshley T. Jones
Ashley T. Jones
JYJian Yang
Jian Yang
ATAndrew Tee
Andrew Tee
CPChristopher Proud
Christopher Proud

1 September 2024 in Access Microbiology
Verified
Journal Article
Open access
AGAmy Louise Green
Amy Louise Green
DBDylan De Bellis
Dylan De Bellis
ECEvangeline Cowell
Evangeline Cowell
RLRoman V. Lenchine
Roman V. Lenchine
TPTimothy Penn
Timothy Penn
JCJillian M Carr
Jillian M Carr
The rat is a useful laboratory model for respiratory diseases. SARS-CoV-2 proteins, such as the spike (S) protein, can induce inflammation. This study has investigated the ability of the Q498Y, P499T (QP-YT) amino acid change, described in the S-protein of the mouse-adapted laboratory SARS-CoV-2 MA strain, to interact with rat angiotensin converting enzyme-2 (ACE2) and stimulate responses in rat lungs. A real-time S–ACE2 quantitative fusion assay shows that ancestral and L452R S-proteins fuse with human but not rat ACE2 expressed on HEK293 (human embryonic kidney-293) cells. The QP-YT S-protein retains the ability to fuse with human ACE2 and increases the binding to rat ACE2. Although lower lung of the rat contains both ACE2 and TMPRSS2 (transmembrane serine protease 2) target cells, intratracheal delivery of ancestral or QP-YT S-protein pseudotyped lentivirus did not induce measurable respiratory changes, inflammatory infiltration or innate mRNA responses. Isolation of primary cells from rat alveoli demonstrated the presence of cells expressing ACE2 and TMPRSS2. Infection of these cells, however, with ancestral or QP-YT S-protein pseudotyped lentivirus was not observed, and the QP-YT S-protein pseudotyped lentivirus poorly infected HEK293 cells expressing rat ACE2. Analysis of the amino acid changes across the S–ACE2 interface highlights not only the Y498 interaction with H353 as a likely facilitator of binding to rat ACE2 but also other amino acids that could improve this interaction. Thus, rat lungs contain cells expressing receptors for SARS-CoV-2, and the QP-YT S-protein variant can bind to rat ACE2, but this does not result in infection or stimulate responses in the lung. Further, amino acid changes in S-protein may enhance this interaction to improve the utility of the rat model for defining the role of the S-protein in driving lung inflammation.

1 September 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
YWYu Wu
Yu Wu
JXJianling Xie
Jianling Xie
XJXin Jin
Xin Jin
RLRoman V. Lenchine
Roman V. Lenchine
XWXuemin Wang
Xuemin Wang
CPChristopher Proud
Christopher Proud
Emerging advances in cancer therapy have transformed the landscape from conventional therapies towards cancer immunotherapy regimens. Recent discoveries have resulted in the development of clinical immune checkpoint inhibitors that are ‘game-changers’ for cancer immunotherapy. Here we show that eEF2K, an atypical protein kinase that inhibits the elongation stage of protein synthesis, actually promotes the synthesis of PD-L1, an immune checkpoint protein which helps cancer cells to escape from immunosurveillance. Ablation of eEF2K in prostate and lung cancer cells markedly reduced the expression levels of the PD-L1 protein. We show that eEF2K promotes the association of PD-L1 mRNAs with translationally active polyribosomes and that translation of the PD-L1 mRNA is regulated by a uORF (upstream open reading-frame) within its 5’-UTR (5’-untranslated region) which starts with a non-canonical CUG codon. This inhibitory effect is attenuated by eEF2K thereby allowing higher levels of translation of the PD-L1 coding region and enhanced expression of the PD-L1 protein. Moreover, eEF2K-depleted cancer cells are more vulnerable to immune attack by natural killer cells. Therefore, control of translation elongation can modulate the translation of this specific mRNA, one which contains an uORF that starts with CUG, and perhaps others that contain a similar feature. Taken together, our data reveal that eEF2K regulates PD-L1 expression at the level of the translation of its mRNA by virtue of a uORF in its 5’-region. This, and other roles of eEF2K in cancer cell biology (e.g., in cell survival and migration), may be exploited for the design of future therapeutic strategies.

4 September 2024
Verified
Preprint
Open access
AGAmy Louise Green
Amy Louise Green
DDDylan Debellis
Dylan Debellis
ECEvangeline Cowell
Evangeline Cowell
RLRoman V Lenchine
Roman V Lenchine
TPTimothy Penn
Timothy Penn
JCJillian M Carr
Jillian M Carr
The rat is a useful laboratory model for respiratory disease, and SARS-CoV-2 proteins such as the spike (S) protein can induce inflammation. This study has investigated the ability of the Q498Y, P499T (QP-YT) amino acid change described in the S-protein of the mouse adapted laboratory SARS-CoV-2 MA strain, to interact with rat angiotensin converting enzyme-2 (ACE2) and stimulate responses in rat lung. Using a real-time S-ACE2 quantitative fusion assay, ancestral and L452R S-protein fuses with human, but not rat ACE2 expressed on HEK293 cells. The QP-YT S-protein retains ability to fuse with human ACE2, and increases binding to rat ACE2. Although rat lower lung contains both ACE2 and TMPRSS2 target cells, intratracheal delivery of ancestral or QP-YT S-protein pseudotyped lentivirus did not induce measurable respiratory changes, inflammatory infiltration, or innate mRNA responses. Isolation of primary cells from rat alveoli demonstrated the presence of cells expressing ACE2 and TMPRSS2. Infection of these cells, however with ancestral or QP-YT S-protein pseudotyped lentivirus was not observed and the QP-YT S-protein pseudotyped lentivirus poorly infected HEK293 cells expressing rat ACE2. Analysis of the amino acid changes across the S-ACE2 interface highlights the Y498 interaction with H353 as a likely facilitator of binding to rat ACE2 but also other amino acids that could improve this interaction. Thus, rat lungs contain cells expressing receptors for SARS-CoV-2 and the QP-YT S-protein variant can bind to rat ACE2 but this does not result in infection or stimulate responses in the lung. Further amino acid changes in S-protein could enhance this interaction to improve the utility of the rat model for defining the role of the S-protein in driving lung inflammation.